Sonic Healthcare (ASX: SHL) — Stock Profile

Sonic Healthcare Limited provides medical diagnostic services alongside administrative services and facilities to medical practitioners across Australia, the United States, Germany, and a number of other international markets. The company operates primarily through laboratory medicine and pathology testing, covering disciplines such as biochemistry, cytopathology, genetics, haematology, histopathology, immunoserology, microbiology, molecular pathology, prenatal testing, and toxicology, as well as a radiology division offering imaging services including MRI, CT, ultrasound, X-ray, mammography, nuclear medicine, PET CT, interventional procedures, and bone mineral densitometry.

Its primary care segment extends the business into general practice clinics, occupational health services, skin cancer clinics, general practice IT solutions, community-based healthcare services, and clinical trials services, reflecting a broad and integrated approach to healthcare delivery. The combination of diagnostic depth and primary care reach positions Sonic Healthcare as a diversified operator across multiple points of the patient care continuum. Incorporated in 1934, the company is headquartered in Sydney, Australia.